Dr. Reddy’s Laboratories Ltd. on Thursday announced a deal with Johnson & Johnson affiliate Janssen Pharmaceutica NV to acquire its anti-vertigo drug under the 'Stugeron' brand for $50.5 million or Rs 445 crore. The local drugmaker will acquire the 'Stugeron' brand, including its key local brands Stugeron FORTE and Stugeron PLUS, as well as its related assets across 18 markets in the Asia-Pacific (APAC) and Europe, Middle East, and Africa (EMEA) regions, with India and Vietnam as key markets, according to a ...